IGKV2-24

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, IGKV2-24 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated IGKV2-24 data layer compared with 3 for mutation status.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher IGKV2-24 RNA is associated with better overall survival. In most high-consensus cancer types, elevated IGKV2-24 expression acts as an unfavorable survival marker, although some lineages such as HNSC and SKCM show a favorable association.

HNSC, SKCM, and BRCA are the cancer types where IGKV2-24 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
HNSCOSMedianAll0.8010.701<.001144view →
SKCMDFSMedianAll0.7280.530<.001106view →
BRCAOSMedianAll0.9780.946<.001103view →
COADDFSMedianAll0.7600.625<.00179view →
CESCDFSQuartileAll0.8240.641.00738view →
UCECOSMedianIII,IV0.6760.473.01328view →
GBMDFSMedianAll0.2000.316.00525view →
LIHCDFSTertileAll0.6140.451.00224view →
LUSCOSQuartileII,III,IV0.4560.678.00315view →
SARCOSTertileAll0.9020.796.01410view →
MESOOSQuartileAll0.6260.110.0069view →
BLCADFSMedianIII,IV0.3140.097.0236view →
Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

IGKV2-24–HNSC (OS)

Kaplan–Meier survival curve for IGKV2-24 RNA-high vs -low samples in HNSC.

Open the HNSC breakdown →

Exploration